Management of Patients with Atrial Fibrillation

American College of Cardiology, American Heart Association, Heart Rhythm Society, American College of Clinical PharmacyPublished: November 30, 2023

Pages:132
Format:Spiral Bound
Dimensions:4.25" x 7.25"

$39.95

A PDF version of this Pocket Guide is also available!

$39.95

Overview
- Top 10 Take-Home Messages for Atrial Fibrillation
Introduction
Management
Figures and Algorithms
- Temporal Trends in Counts and Age-Standardized Rates of AF-Prevalent Cases by Social Demographic Index (SDI) Quintile for Both Sexes Combined, 1990 to 2017
- Prevalence of AF Among Medicare Beneficiaries, 1993–2007
- Age-Standardized Global Prevalence Rates of AF and Atrial Flutter (AFL) per 100,000, Both Sexes, 2020
- AF Stages: Evolution of Atrial Arrhythmia Progression
- Pillars for AF Management
- Types of Atrial Flutter and Macroreentrant Atrial Tachycardia
- Mechanisms and Pathways Leading to AF
- Contemporary Summary of the Role of the ANS in AF
- Rates of Stroke by Stroke Risk Score Levels in Different Cohorts
- Antithrombotic Options in Patients with AF
- DOAC Laboratory Monitoring
- Consideration of Oral Anticoagulation for Device-Detected AHREs According to Patient Stroke Risk by CHA2DS2-VASc Score and Episode Duration
- Active Bleeding Associated with Oral Anticoagulant
- Forms of ICH, Classified by Mechanism
- Flowchart: Management of Periprocedural Anticoagulation in Patients With AF
- Anticoagulation for Typical (CTI-Dependent) AFL
- Acute Rate Control in AF With Rapid Ventricular Response (RVR)
- AF Long-Term Rate Control
- Patient and Clinical Considerations for Choosing Between Rhythm Control and Rate Control
- Flowchart for Treatment Choices When Required to Decrease AF Burden
- Patients With Hemodynamically Stable AF Planned for Cardioversion
- Treatment Algorithm for Pharmacological Conversion of AF to Sinus Rhythm
- Treatment Algorithm for Drug Therapy for Maintenance of Sinus Rhythm
- Management of Patients with HF and AF
- Prevention of AF After Cardiac Surgery
- Treatment of AF After Cardiac Surgery
- Unadjusted Cumulative Risk of AF Recurrence
- Acute Medical or Surgical Illness
Tables
- Risk Factors for Diagnosed AF
- Definitions
- Table of Publicly Available Decision Aids
- CHARGE-AF Risk Score for Detecting Incident AF
- C2HEST Risk Score for Detecting Incident AF
- Three Validated Risk Models for Stroke
- Some Best Known Published Clinical Scores With Potential Advantages
- Risk Factor Definitions for CHA2DS2-VASc Score as in the Original Article
- Factors That Increase the Risk of Stroke
- Thromboembolic Event Rates by Point Score for ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores
- OACs Pharmacokinetic Characteristics and Dosing
- Situations in Which Long-Term Anticoagulation Is Contraindicated and Situations When It Remains Reasonable
- Reversal Agents for Oral Anticoagulants
- Bleeding Events (Precent/Year) in Direct Oral Anticoagulant Pivotal Clinical Trials
- Risk Factors for Thromboembolic Complications and Recurrent ICH
- Timing of Discontinuation of Oral Anticoagulants in Patients With AF Scheduled to Undergo an Invasive Procedure or Surgery in Whom Anticoagulation is to Be Interrupted
- Recommended Doses of Currently Approved DOACs According to Renal Function
- Clinical Presentations and Objectives of Heart Rate Control
- Pharmacological Agents for Rate Control in Patients With Atrial Fibrillation
- Drugs for Pharmacological Conversion of Atrial Fibrillation to Sinus Rhythm
- Specific Drug Therapy for Maintenance of Sinus Rhythm in Patients With Atrial FibrillationRecommended Monitoring for Patients Taking Oral Amiodarone
- Recommended Monitoring for Patients Taking Other Antiarrhythmic Drugs
- Complications After Atrial Fibrillation Catheter Ablation
- Anticoagulation Strategies During Pregnancy - Antenatal Options
- Medical Cancer Therapy Associated With Increased Risk of AF (>1%)
- Special Considerations for Anticoagulation in Patients With AF on Active Cancer Treatment